New York, NY-- The Lymphoma Research Foundation (LRF) announced today that Bruce D. Cheson, M.D., Head of Hematology and Director of Hematology Research at the Lombardi Comprehensive Cancer Center of Georgetown University Medical Center was named Chairman-elect of the organization’s Scientific Advisory Board (SAB). The SAB, a volunteer group of the nation's leading lymphoma researchers and clinicians, provides strategic direction for the organization’s overall scientific agenda. Dr. Cheson has been a member since 2001.
In addition to his role with the Scientific Advisory Board, Dr. Cheson and his wife, Christine, organized LRF’s first annual Lymphoma Research Ride this past September. Over 100 riders participated in this non-competitive 25- or 50-mile event which raised over $350,000 for lymphoma specific research and programming.
Dr. Cheson has more than 300 publications and expertise in both clinical and research medicine. A graduate of the University of Virginia and Tufts University Medical School, he completed his internship and residency in Internal Medicine at the University of Virginia Hospitals and his clinical and research fellowship in Hematology at New England Medical Center Hospital.
Dr. Cheson is a renowned member of numerous editorial boards and is Associate Editor of the Journal of Clinical Oncology, Oncology, and Oncology News International. He is an Editor-in-Chief of Clinical Lymphoma and Myeloma and Clinical Advances in Hematology and Oncology. He currently chairs the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB), a National Cancer Institute-supported clinical trial cooperative group, and is co-chair of the International Harmonization Project in Lymphoma, an international team of cancer specialists and imaging experts, and the American Joint Committee on Cancer Subcommittee on Lymphoma.
”I am honored to be selected as the Chairman-elect of LRF’s Scientific Advisory Board,” said Dr. Cheson. “With its singular focus on lymphoma and the active involvement of patients, caregivers, and medical professionals, the Foundation is destined to be an active participant in finding a cure for this disease.”
Currently there are over 500,000 Americans living with some form of lymphoma. It is the most common blood cancer and the third most common cancer of childhood. Lymphoma is a cancer of the lymphatic system that can develop when an error occurs in the way a lymphocyte (type of white blood cell that helps the body fight infection) is produced, resulting in an abnormal cell. It is not one disease, but rather a complex combination of at least 30 closely-related cancers that affect the lymphatic system, many of which are rare diseases. The many forms of lymphoma are broadly categorized into Hodgkin lymphoma and non-Hodgkin lymphoma (includes B-cell and T-cell diseases).
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest voluntary health organization devoted exclusively to funding lymphoma research and providing patients and health care professionals with critical information on the disease. LRF's mission is to eradicate lymphoma and serve those touched by this disease.
More than 85 cents of every dollar spent goes to research and programming. As of the close of FY 2006, LRF has funded $34.7 million in lymphoma-specific research. LRF also provides a comprehensive series of programs and services for patients, survivors and loved ones affected by lymphoma, including our toll-free Lymphoma Helpline and Clinical Trials Information Service, in-person patient education programs, webcasts/teleconferences and support services. For more information, visit www.lymphoma.org
About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 39 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through our partnership with MedStar Health). Our mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.